Search

everythinglearnresearchcommunity

for

Search:↓

Compounds from Pterocarpus indicus may help treat benign prostatic hyperplasia by stopping cell growth.

JAK inhibitors show promise in treating difficult skin diseases.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

MOTILIPERM may help treat male infertility by reducing stress in cells.

JAK inhibitors have therapeutic potential but pose significant risks, requiring careful monitoring.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Oral JAK inhibitors effectively treat alopecia areata and are generally well-tolerated.

JAK inhibitors show promise for treating various skin diseases.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

JAK inhibitors help hair growth by boosting beta-catenin activity in hair root cells.

Inhibiting EGFR weakens skin's defense against bacteria.

New hybrid compound found to effectively prevent hair loss.

PRIDE syndrome helps identify skin side effects from EGFR inhibitors like erlotinib.

JAK inhibitors effectively treat skin conditions and topical forms are safer.

Merremia peltata leaf extract, particularly the bufotalinin compound, shows potential for treating hair loss.

New treatments for cancer and skin disorders show promise in disrupting harmful cell interactions and promoting hair growth.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

The MAPK/ERK pathway is crucial in controlling cell growth and death in finasteride-induced hypospadias.

Avicennia marina shows potential to treat Hepatitis C by targeting key proteins.

Certain inhibitors slow down plant growth by causing early cell specialization without changing the cell development pattern.

Some natural compounds from Iris plants can block enzymes related to certain disorders, with a few affecting both targeted enzymes.

The substance MK386 effectively blocked testosterone conversion and reduced cell growth in certain skin cells, but inhibiting 5α-reductase alone may not greatly improve acne.